Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serge Gauthier

Showing results (291-300 of 370) with videos related to

Pageof 37
Sort By:
Brain Communications|May 30, 2023
Verbal memory formation across PET-based Braak stages of tau accumulation in Alzheimer's diseaseJaime Fernández Arias, Joseph Therriault, Emilie Thomas, et al.
The Lancet. Neurology|October 12, 2010
Revising the definition of Alzheimer's disease: a new lexiconBruno Dubois, Howard H Feldman, Claudia Jacova, et al.
Alzheimer'S Research & Therapy|March 30, 2021
Plasma pTau181 predicts cortical brain atrophy in aging and Alzheimer's diseaseCécile Tissot, Andréa L Benedet, Joseph Therriault, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 22, 2020
Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trialsJin-Tai Yu, Wei Xu, Chen-Chen Tan, et al.
Neurology|August 21, 2024
Influence of Different Diagnostic Criteria on Alzheimer Disease Clinical ResearchAndrei Bieger, Wagner S Brum, Wyllians V Borelli, et al.
Brain Communications|January 23, 2025
Identify biological Alzheimer's disease using a novel nucleic acid-linked protein immunoassayYi-Ting Wang, Nicholas J Ashton, Joseph Therriault, et al.
CNS Drugs|December 1, 2025
Hippocampal Atrophy on Magnetic Resonance Imaging as a Surrogate Marker for Clinical Benefit and Neurodegeneration in Early Symptomatic Alzheimer's Disease: Synthesis of Evidence from Observational and Interventional TrialsSusan Abushakra, P Murali Doraiswamy, John A Hey, et al.
Archives of Neurology|January 21, 2004
Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trialsMichael Grundman, Ronald C Petersen, Steven H Ferris, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 15, 2025
Rates of clinical progression according to biological Alzheimer's disease stagesLydia Trudel, Joseph Therriault, Arthur C Macedo, et al.
Neurology|March 6, 2023
Potential Utility of Plasma P-Tau and Neurofilament Light Chain as Surrogate Biomarkers for Preventive Clinical TrialsPamela C L Ferreira, João Pedro Ferrari-Souza, Cécile Tissot, et al.
Pageof 37

Showing results (291-300 of 370) with videos related to

Sort By:
Pageof 37
Brain Communications|May 30, 2023
Verbal memory formation across PET-based Braak stages of tau accumulation in Alzheimer's diseaseJaime Fernández Arias, Joseph Therriault, Emilie Thomas, et al.
The Lancet. Neurology|October 12, 2010
Revising the definition of Alzheimer's disease: a new lexiconBruno Dubois, Howard H Feldman, Claudia Jacova, et al.
Alzheimer'S Research & Therapy|March 30, 2021
Plasma pTau181 predicts cortical brain atrophy in aging and Alzheimer's diseaseCécile Tissot, Andréa L Benedet, Joseph Therriault, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 22, 2020
Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trialsJin-Tai Yu, Wei Xu, Chen-Chen Tan, et al.
Neurology|August 21, 2024
Influence of Different Diagnostic Criteria on Alzheimer Disease Clinical ResearchAndrei Bieger, Wagner S Brum, Wyllians V Borelli, et al.
Brain Communications|January 23, 2025
Identify biological Alzheimer's disease using a novel nucleic acid-linked protein immunoassayYi-Ting Wang, Nicholas J Ashton, Joseph Therriault, et al.
CNS Drugs|December 1, 2025
Hippocampal Atrophy on Magnetic Resonance Imaging as a Surrogate Marker for Clinical Benefit and Neurodegeneration in Early Symptomatic Alzheimer's Disease: Synthesis of Evidence from Observational and Interventional TrialsSusan Abushakra, P Murali Doraiswamy, John A Hey, et al.
Archives of Neurology|January 21, 2004
Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trialsMichael Grundman, Ronald C Petersen, Steven H Ferris, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 15, 2025
Rates of clinical progression according to biological Alzheimer's disease stagesLydia Trudel, Joseph Therriault, Arthur C Macedo, et al.
Neurology|March 6, 2023
Potential Utility of Plasma P-Tau and Neurofilament Light Chain as Surrogate Biomarkers for Preventive Clinical TrialsPamela C L Ferreira, João Pedro Ferrari-Souza, Cécile Tissot, et al.
Pageof 37